PlainRecalls
FDA Drug Low Class III Terminated

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Reported: July 5, 2017 Initiated: June 12, 2017 #D-0926-2017

Product Description

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Reason for Recall

Superpotent Drug: high out-of-specification result for magnesium.

Details

Recalling Firm
Sanofi-Aventis U.S. LLC
Units Affected
2980 bottles
Distribution
Nationwide in the USA, Puerto Rico, and the United Kingdom.
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.. Recalled by Sanofi-Aventis U.S. LLC. Units affected: 2980 bottles.
Why was this product recalled?
Superpotent Drug: high out-of-specification result for magnesium.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 5, 2017. Severity: Low. Recall number: D-0926-2017.